Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)

Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)

Bibliographic Details
Main Authors:	Brito RG, Nascimento CB, Fernandes TAP, Sato JO, Saad-Magalhães C
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

INTRAARTICULAR STEROIDS IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: A SINGLE CENTER EXPERIENCE
by: Cosickic Almira, et al.
Published: (2021-05-01)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
by: Davì S, et al.
Published: (2008-09-01)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
by: Davì S, et al.
Published: (2011-09-01)

Total hip arthroplasty in patients with active psoriatic arhtritis (preliminary report)
by: D. V. Volchenko, et al.
Published: (2021-07-01)

Outcome predictors in patients with juvenile idiopathic arthritis receiving intraarticular corticosteroid therapy
by: Anindya Diwasasri, et al.
Published: (2019-09-01)

Are intraarticular steroids effective for knee osteoarthritis?
by: Jorge Faúndez, et al.
Published: (2016-12-01)

Talus Arthritis Pattern in Juvenile Idiopathic Arthritis (JIA)
by: Mohammad Alkhreisat MD, et al.
Published: (2019-10-01)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
by: Zak M, et al.
Published: (2008-09-01)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
by: Carlomagno R, et al.
Published: (2011-09-01)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
by: Alpigiani MG, et al.
Published: (2008-09-01)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
by: Bracaglia C, et al.
Published: (2008-09-01)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008-09-01)

Parent and Patient Treatment Preferences in Juvenile Idiopathic Arthritis (JIA)
by: Montealegre Sanchez, Gina A.
Published: (2011)

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)
by: M. Bielak, et al.
Published: (2018-04-01)

Psoriasis and Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis (JIA) : A Longitudinal Study of the Nordic JIA Cohort
by: Ekelund, Maria
Published: (2020)

Replication of the association of the <it>COG6</it> gene with juvenile idiopathic arthritis (JIA)
by: Worthington J, et al.
Published: (2011-09-01)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
by: Verazza S, et al.
Published: (2008-09-01)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
by: Baildam EM, et al.
Published: (2008-09-01)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
by: van Rossum MAJ, et al.
Published: (2011-09-01)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
by: Hinze CH, et al.
Published: (2008-09-01)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
by: Dehoorne J, et al.
Published: (2011-09-01)

Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
by: Stepanenko NY
Published: (2011-09-01)

How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
by: Nageswaran Savithri, et al.
Published: (2008-06-01)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008-09-01)

Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA)
by: Jelusic-Drazic Marija, et al.
Published: (2012-07-01)

Accuracy of preliminary remission criteria some JIA category
by: Fantini F, et al.
Published: (2008-09-01)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
by: Espada Graciela, et al.
Published: (2011-09-01)

Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa
by: Pope Chris, et al.
Published: (2011-09-01)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
by: Filocamo G, et al.
Published: (2008-09-01)

Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)
by: Kumar Sharath, et al.
Published: (2012-11-01)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
by: Lattanzi B, et al.
Published: (2008-09-01)

German evidence- and consensus-based guidelines 2011 for the treatment of juvenile idiopathic arthritis (JIA)
by: Dueckers Gregor, et al.
Published: (2012-07-01)

Knee disease in juvenile idiopathic arthritis (JIA): correlation between clinical and ultrasonographic findings
by: McCarron M, et al.
Published: (2008-09-01)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008-09-01)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
by: Bullement A, et al.
Published: (2021-09-01)

Immune regulation in health and Juvenile Idiopathic Arthritis (JIA) : molecular mechanisms and regulatory T cells
by: Pesenacker, A. M.
Published: (2013)

Impaired Muscular Fat Metabolism in Juvenile Idiopathic Arthritis in Inactive Disease
by: Emmanuelle Rochette, et al.
Published: (2019-05-01)

An evaluation of the utility of routine laboratory monitoring of juvenile idiopathic arthritis (JIA) patients using non-steroidal anti-inflammatory drugs (NSAIDs): a retrospective review
by: Nocton James J, et al.
Published: (2010-04-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
by: Cohen Jean-David, et al.
Published: (2012-07-01)